Grantclosed🌐 United StatesRFA-DK-21-012
Support for Small Business Innovation Research (SBIR) to Development and Testing of New Technologies and Bioengineering Solutions for the Advancement of Cell Replacement Therapies for Type 1 Diabetes (R43/R44 Clinical Trial Not Allowed)
National Institutes of Health
Details?
- Posted
- May 19, 2021
- Response deadline
- Oct 7, 2022, 12:00 AM UTC
- Type
- Grant
- Category
- 93.847
- Status
- closed
- Buyer
- National Institutes of Health
- Department
- HHS-NIH11
- Jurisdiction
- United States
- Reference #
- RFA-DK-21-012
- Doc Type
- synopsis
- Opp Status
- archived
Finding similar opportunities…
This listing is a summary from United States's open procurement data. We ingest every field the feed publishes; the full solicitation documents are on the source portal.
Raw record
{
"id": "333668",
"title": "Support for Small Business Innovation Research (SBIR) to Development and Testing of New Technologies and Bioengineering Solutions for the Advancement of Cell Replacement Therapies for Type 1 Diabetes (R43/R44 Clinical Trial Not Allowed)",
"agency": "National Institutes of Health",
"number": "RFA-DK-21-012",
"docType": "synopsis",
"cfdaList": [
"93.847"
],
"openDate": "05/19/2021",
"closeDate": "10/07/2022",
"oppStatus": "archived",
"agencyCode": "HHS-NIH11"
}